article · Toxicology Reports

Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs

Ochuko L. Erukaınure
Ya'qub U Abiodun
Olubunmi Atolanı
Robert Preißner
Aliyu Muhammad
Rahul Ravichandran
Murtala Bello Abubakar
Sanusi B. Katsayal
Musa M. Abarshi
Priyanka Banerjee

2024Open accessUniversity of Ilorin

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
PARP inhibition in cancer therapy

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.toxrep.2024.101825

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.